PrabhaViswanathanMD

Pediatric Infectious Disease • Washington, DC

Physician

Join to view full profile

Dr. Viswanathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Viswanathan's full profile

Already have an account?

Office
111 Michigan Ave NW
Ste 100
Washington, DC 20010
Phone+1 202-476-6151

Fax+1 202-476-3850

Education & Training

Children's National Hospital/George Washington UniversityFellowship, Pediatric Infectious Diseases, 2010 - 2013
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2003 - 2006
University of Kansas School of MedicineClass of 2003

Certifications & Licensure

DC State Medical License 2010 - 2024
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Infectious Diseases

Publications & Presentations

PubMed

Clinical fellowship augmented by regulatory review experience: a perspective on the Children's National Hospital/FDA fellowship tracks.
Jency Daniel, Nicholas Geagan, Nada Harik, Debra Birnkrant, Ramya Gopinath
Proceedings. 2024-01-01
28 citations
Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint.
Sarita D. Boyd, Mario R Sampson, Prabha Viswanathan, Kimberly A Struble, Vikram Arya
AIDS. 2019-05-01
2 citations
Effects of Sorbitol on the Pharmacokinetics of Lamivudine Solution and the FDA's Decision to Increase the Dose of Lamivudine Solution for Pediatric Patients.
Su-Young Choi, Prabha Viswanathan, Adam Sherwat, Shirley Seo
Clinical Pharmacology and Therapeutics. 2018-11-01

Journal Articles

Effects of Sorbitol on the Pharmacokinetics of Lamivudine Solution and the FDA's Decision to Increase the Dose of Lamivudine Solution for Pediatric Patients
Prabha Viswanathan, MD, Clinical Pharmacology & Therapeutics

Press Mentions

Schools Should Normalize Pauses for Coronavirus SafetyJanuary 25th, 2022